Cart summary

You have no items in your shopping cart.

    Disialoganglioside 2 Antibody

    Disialoganglioside 2 Antibody

    Catalog Number: orb1906419

    DispatchUsually dispatched within 5-10 working days
    $ 531.00
    Catalog Numberorb1906419
    CategoryAntibodies
    DescriptionDisialoganglioside 2 Antibody
    Species/HostMouse
    ClonalityMonoclonal
    Clone Number14G2a
    Tested applicationsELISA, FC
    ReactivityHuman
    IsotypeIgG2a
    ImmunogenThe original murine parent antibody was generated against human neuroblastoma cell line LAN-1. This IgG2a isotype version was then generated by class switching of the murine parent antibody 14.18 (IgG3).
    Concentration1 mg/ml
    ConjugationUnconjugated
    TargetDisialoganglioside 2
    StorageStore at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
    Buffer/PreservativesPBS with 0.02% Proclin 300.
    Alternative namesGD2
    Read more...
    NoteFor research use only
    Application notesThis antibody is a IgG2a isotype switch variant of the murine parent antibody 14.18. This antibody can direct efficient complement-dependent cytotoxicity against neuroblastoma tumor cells and melanoma cell lines in vitro in the presence of human complement (PMID: 2720646). 14G2a was coupled to the ribosome-inactivating plant toxin gelonin with the heterobifunctional cross-linking reagentN-succinimidyl-3(2-pyridyldithio)propionate. The immunoreactivity and specificity of 14G2a-gelonin immunotoxin determined by ELISA. Assays for complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) revealed that these functional properties of the native 14G2a antibody were also preserved in the 14G2a-gelonin immunotoxin (PMID: 1756537). An immunotoxin prepared by linked 14G2a via the bivalent linker N-succinimidyloxycarbonyl-amethyl-a-(2-piridyldithio)toluene to deglycosylated ricin A chain was shown to inhibit the protein synthesis of neuroblastoma cell lines IMRS and NMB (Gottstein et al., 1994). Treatment with 14G2a mAb (1–4 mg/kg cumulative dose given as five i.v. daily administrations) dramatically reduced the metastatic spread of NB cells and prolonged the long-term survival of treated mice in a dose-dependent manner (PMID: 12880983). This antibody is also reported to be used in the study of interactions between peptides mimicking the GD2 ganglioside using flow ctyometry and ELISA (PMID: 21455557).
    Expiration Date12 months from date of receipt.
    • Disialoganglioside 2 Antibody [orb1906418]

      ELISA,  FC

      Human

      Mouse

      Monoclonal

      Unconjugated

      0.2 mg
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars